StartEngine
Loading investments…
StartEngine
Loading investments…
StartEngine
Loading offering details…
StartEngine
Loading offering details…
INVEST IN BARRICADE THERAPEUTICS · BIOTECHNOLOGY
Barricade is developing BT-1501, a pill designed to treat colorectal cancer caused by mutation to the APC gene, found in about 80% of colorectal cancer patients. The company has secured over $20 million to date, including $17 million in non-dilutive grant funding from the Cancer Prevention & Research Institute of Texas (CPRIT), plus backing from the American Cancer Society. Barricade is preparing to begin its first human clinical trial, with a planned start in 1H 2027.
This Reg CF offering is made available through StartEngine Primary, LLC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment.
Total Capital Raised
$20,000,000+
Interest Rate
8%
Minimum Investment
$500
Once the four-hour window has passed, it is up to each company to set their own cancellation policy. You may find the company’s cancellation policy in the company’s offering circular. Once your investment is canceled, there is a 10-day clearing period from the date your investment was submitted. After your funds have cleared the bank, you will receive your refund within 10 business days. Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible.
However, every investment needs to go through the clearing process in order to be sent back to the account associated with the investment.
Both Title III Regulation Crowdfunding and Title IV Regulation A+ help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, learn about Regulation Crowdfunding, and for Regulation A+, learn about Regulation A+.